Increased reliance on fatty acid oxidation (FAO) alters mitochondrial electron flux and redox cofactor dynamics, influencing both anaboliccatabolic balance and oxidative buffering capacity
Current Options While Waiting for Retatrutide As exciting as Retatrutide's potential may be, it is still in clinical trials, and Retatrutide clinical trials continue to evaluate its efficacy and safety
Patients using GLP-1 medications should maintain contact with their Hers provider and a primary care physician to coordinate care, report persistent side effects, and address any signs of dehydration, acute abdominal pain, or thyroid symptoms
Although early studies have shown promising Retatrutide weight loss results, future availability in the UK will depend on further clinical evidence and regulatory review
Ros menu is almost entirely FDA-approved: Wegovy, Zepbound, Foundayo (approved April 1, 2026), and Ozempic off-label